免疫系统
医学
淋巴系统
免疫疗法
癌症
抗原
生物
癌症研究
免疫学
病理
遗传学
作者
Nicolas Jacquelot,Julie Tellier,Stephen L. Nutt,Gabrielle Therese Belz
出处
期刊:OncoImmunology
[Landes Bioscience]
日期:2021-01-01
卷期号:10 (1): 1900508-1900508
被引量:142
标识
DOI:10.1080/2162402x.2021.1900508
摘要
Tertiary lymphoid structures (TLS) are ectopic cellular aggregates that resemble secondary lymphoid organs in their composition and structural organization. In contrast to secondary lymphoid organs, TLS are not imprinted during embryogenesis but are formed in non-lymphoid tissues in response to local inflammation. TLS structures exhibiting a variable degree of maturation are found in solid tumors. They are composed of various immune cell types including dendritic cells and antigen-specific B and T lymphocytes, that together, actively drive the immune response against tumor development and progression. This review highlights the successive steps leading to tumor TLS formation and its association with clinical outcomes. We discuss the role played by tumor-infiltrating B lymphocytes and plasma cells, their prognostic value in solid tumors and immunotherapeutic responses and their potential for future targeting.
科研通智能强力驱动
Strongly Powered by AbleSci AI